10-K
Annual Report
AGENUS INC
AGEN
NASDAQ
CIK: 1098972
File #: 000-29089
Balance Sheet
45 line items · 2 periods
XBRL
| Item | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|
ASSETS | ||
Cash and cash equivalents | 76,110,000 | 178,674,000 |
Short-term investments | — | 14,684,000 |
Short Term Investments | — | 14,700,000 |
Accounts receivable | 25,836,000 | 2,741,000 |
Prepaid expenses | 8,098,000 | 13,829,000 |
Other current assets | 2,372,000 | 3,194,000 |
Total current assets | 112,416,000 | 213,122,000 |
Property, plant and equipment, net of accumulated amortization and depreciation of $61,943 and $54,075 at December 31, 2023 and 2022, respectively | 133,421,000 | 133,017,000 |
Operating lease right-of-use assets | 29,606,000 | 31,269,000 |
Goodwill | 24,723,000 | 25,467,000 |
Acquired intangible assets, net of accumulated amortization of $17,688 and $16,148 at December 31, 2023 and 2022, respectively | 4,411,000 | 6,228,000 |
Other long-term assets | 9,336,000 | 4,453,000 |
Total assets | 313,913,000 | 413,556,000 |
LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT | ||
Current portion, long-term debt | 146,000 | 575,000 |
Current portion, liability related to sale of future royalties and milestones | 132,502,000 | 83,510,000 |
Current portion, deferred revenue | 18,000 | 12,269,000 |
Current portion, operating lease liabilities | 2,587,000 | 1,943,000 |
Accounts payable | 61,446,000 | 40,939,000 |
Accrued liabilities | 45,283,000 | 38,259,000 |
Other current liabilities | 13,915,000 | 11,457,000 |
Total current liabilities | 255,897,000 | 188,952,000 |
Long-term debt, net of current portion | 12,768,000 | 12,584,000 |
Liability related to sale of future royalties and milestones, net of current portion | 124,556,000 | 187,753,000 |
Deferred revenue, net of current portion | 1,143,000 | 1,143,000 |
Operating lease liabilities, net of current portion | 62,511,000 | 63,326,000 |
Other long-term liabilities | 5,420,000 | 14,700,000 |
STOCKHOLDERS' DEFICIT | ||
Series A-1 convertible preferred stock | 0 | 0 |
Common stock, par value $0.01 per share; 800,000,000 shares authorized at December 31, 2023 and 2022; 394,373,240 shares and 305,573,397 shares issued at December 31, 2023 and 2022, respectively | 3,944,000 | 3,056,000 |
Additional paid-in capital | 1,792,348,000 | 1,644,658,000 |
Accumulated other comprehensive (loss) income | (955,000) | 915,000 |
Accumulated deficit | (1,955,668,000) | (1,709,907,000) |
Total stockholders' deficit attributable to Agenus Inc. | (160,331,000) | (61,278,000) |
Non-controlling interest | 11,949,000 | 6,376,000 |
Non-controlling Interest | 11,949,000 | 6,376,000 |
Total stockholders' deficit | (148,382,000) | (54,902,000) |
Additional Paid-in Capital | 1,792,348,000 | 1,644,658,000 |
Series A-1 convertible preferred stock - Preferred Stock | 0 | 0 |
Non-controlling Interest | 11,949,000 | 6,376,000 |
Accumulated Other Comprehensive Income (Loss) | (955,000) | 915,000 |
Accumulated Deficit | (1,955,668,000) | (1,709,907,000) |
Common Stock | 3,944,000 | 3,056,000 |
Total liabilities, convertible preferred stock and stockholders' deficit | 313,913,000 | 413,556,000 |